Data / Form D filings / China Biologic Products, Inc.
China Biologic Products, Inc.: Form D filing
China Biologic Products, Inc., a pharmaceuticals company in Tai'An City, Shandong, filed a Form D with the SEC in 2009. The latest, on June 26, 2009, reports $9.6 million sold of a $9.6 million offering to 3 investors.
Find out what China Biologic Products, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- NO.14 EAST HUSHAN ROAD, Tai'An City, Shandong, 27100
- Phone
- 011-86-5386206626
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- China
- Year incorporated
- 2007
- Revenue range
- $25,000,001 - $100,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1369868
The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 26, 2009 | New notice | $9,554,140 | $9,554,140 | $0 | 3 | Jun 10, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Siu Ling Chan | Director | |
| Chao Ming Zhao | Executive Officer | |
| Sean Shao | Director | |
| Jie Gan | Director | |
| Tong Jun Lin | Director | |
| Ling Lin Li | Director | |
| Yun-Yun Tristan Kuo | Executive Officer |
Every Form D from the week of Jun 22, 2009 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what China Biologic Products, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.